Prezista Extends HIV Suppression in Children (CME/CE)

KUALA LUMPUR (MedPage Today) -- Children with human immunodeficiency virus (HIV) maintain viral control over 48 weeks when treated with the protease inhibitor darunavir/ritonavir (Prezista) along with an optimized background regimen, researchers reported here.

Source: MedPage Today State Required CME - July 6, 2013 Category: Consumer Health News Source Type: news